Biological Therapeutics

Program Overview

Biological Therapeutics at the University of Warsaw is a two-year, English-taught Master’s degree in pharmaceutical biotechnology, run by the Faculty of Medicine in Warsaw, Poland. Delivered in laboratories on the Ochota Campus, it integrates exact and natural sciences with medicine and focuses on the design, production and quality control of biological drugs.

What sets this biotechnology degree in Poland apart is its laboratory intensity: block teaching allows complex, multi-stage experiments rather than short classes, and the program is open to graduates of any field who are ready for demanding scientific work. Delivered within the European-funded ZIP 2.0 development programme, it adds mentoring and research support; full details sit on the official program page.

What You Will Study

In Biological Therapeutics at the University of Warsaw, students may study the design and in-vitro synthesis of nucleic-acid-based biological drugs, including therapeutic mRNA, alongside the molecular mechanisms of biological drugs, pharmaceutical biophysics, protein purification and cellular production systems. Preclinical study design with cell cultures and animal models, drug delivery via lipid nanoparticles, and ethical animal-model creation with CRISPR-Cas9 also feature.

The curriculum extends to modern analytical and sequencing techniques such as nanopore, genetic-modification technologies, and the regulatory, patent, financial and management sides of drug development. Skills-wise, students plan and run biotech experiments, analyse publications and patents, and use bioinformatics for drug design. There are no specialisations; the full study programme is on the official page.

Who This Program May Suit

Biological Therapeutics at the University of Warsaw may suit students with a background in biotechnology, molecular biology, biochemistry, chemistry, pharmacy or medicine who want to move into biological drug development, though graduates of any field can apply. It can be relevant for people excited by mRNA therapeutics, protein drugs and cutting-edge lab methods.

Because teaching is laboratory-intensive and admission depends on an in-person English interview based on set literature, the degree may appeal most to methodical, research-minded applicants who can discuss scientific topics clearly and are ready for long lab days. Weighing your background and interview readiness against the program with the StudyFits AI Advisor can be a useful first step.

Admission Fit & Requirements

For Biological Therapeutics at the University of Warsaw, applicants should review two things carefully: the language prerequisite and the interview. English at B2+ is a strict requirement, and without accepted proof a candidate scores zero and is disqualified. Any degree background is eligible, though a relevant field and grades around 70% or higher are expected for this moderately competitive program.

Admission is decided by a single in-person interview in English, held in Warsaw and scored out of 90 with a minimum of 60, with an optional Research Experience Letter adding up to 10 points. Foreign diplomas may need an apostille, sworn translation and, depending on the issuing country, a NAWA recognition statement. A profile check with the StudyFits AI Advisor can help before you commit.

Tuition Fees & Cost Signal

For Biological Therapeutics at the University of Warsaw, students should review costs by citizenship: EU/EFTA and Swiss citizens study free of charge, while other international students pay 3,000 EUR per year, roughly 6,000 EUR across the two-year program, transferred to an individual account after admission. The application fee is 100 PLN, the rate for fields with an additional check such as this interview.

While no standalone tuition scholarship is offered, the program runs within the European-funded ZIP 2.0 initiative, which supports student research, mentoring and study trips, and NAWA plus university-level support may add options. Comparing this cost signal with similar biotech MAs is easy with the StudyFits AI Advisor.

Career Paths & Future Options

Students considering Biological Therapeutics at the University of Warsaw may use this program to move toward the biotechnology and biopharmaceutical industry. According to the program’s description, graduates can work in the research, development and production departments of biotechnology and biopharmaceutical companies, in the innovative biological and biosimilar drug-production sector, and in the modern pharmaceutical industry.

The hands-on training in drug design, production technologies, quality control and regulatory aspects builds skills that map directly onto industry roles, while the research orientation also supports doctoral study. Since career direction stays individual, matching these possible paths against your own goals is worthwhile, and the StudyFits AI Advisor can help with a profile-based comparison.

Study Location Advantage

Studying Biological Therapeutics at the University of Warsaw in Warsaw, Poland places students on the Ochota Campus, a concentrated science and medicine hub with laboratories at the Faculty of Physics and the International Institute of Molecular and Cell Biology. For a lab-intensive biotech degree, proximity to well-equipped research facilities is a practical advantage.

Warsaw combines an active international student community with relatively accessible European living costs, and studying in Poland keeps students inside the EU higher-education area, which also supports exchange options such as MOST and Erasmus+. Anyone comparing Warsaw with other biotech study destinations can ask the StudyFits AI Advisor for location-based guidance.

Compare This Program With AI Advisor

Before choosing Biological Therapeutics at the University of Warsaw, students can use the StudyFits AI Advisor to compare this MA with other biotechnology, pharmaceutical-sciences and molecular-biology programs across universities and countries. The Advisor reviews academic background, English level, budget and study goals, and helps test whether a lab-intensive, interview-based program fits your plans.

A short conversation can surface alternatives you had not considered, or confirm this choice with more confidence. For personal support, the enquiry form on this page connects you with the StudyFits team at no obligation.

FAQ

Q: What is the Biological Therapeutics MA at the University of Warsaw about?
A: It is a two-year, English-taught Master’s degree in pharmaceutical biotechnology run by the Faculty of Medicine, focused on designing and producing biological drugs such as therapeutic mRNA and protein drugs through laboratory-intensive, block-taught study.

Q: Can I study Biological Therapeutics in Warsaw without a biotech degree?
A: Yes. The program accepts graduates of any field, though a relevant science background and solid grades help, since it is moderately competitive and admission depends on an in-person interview; exact rules should be checked on the official page.

Q: What is the admission process for Biological Therapeutics at the University of Warsaw?
A: Admission rests on a single in-person English interview in Warsaw, scored out of 90 with a minimum of 60. English proof at B2+ is a strict prerequisite, and an optional Research Experience Letter can add points.

Q: How much does this English-taught biotech MA in Poland cost?
A: Tuition is free for EU/EFTA and Swiss citizens and 3,000 EUR per year for other international students, plus a 100 PLN application fee. Current fees should be confirmed on the official program page.

Q: How can I compare this program with similar options?
A: The StudyFits AI Advisor can compare this MA with other biotechnology and pharmaceutical programs based on your background, budget and goals, and the enquiry form on this page offers personal guidance.